Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05750368 |
Other study ID # |
women-epigastric |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
September 1, 2022 |
Est. completion date |
February 1, 2023 |
Study information
Verified date |
March 2023 |
Source |
Bispebjerg Hospital |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The aim was to evaluate outcomes after epigastric hernia repair in women on a nationwide
basis. The primary outcome iss recurrence - secondary outcomes are readmission, operation for
complication, risk factors for recurrence, and readmittance.
Description:
Aim Outcomes after epigastric hernia repair are rarely reported independently. Furthermore,
women have the highest prevalence of epigastric hernia repair in the age of 41-50 years.
The aim of this study was to evaluate long-term outcomes after epigastric hernia repairs in
women on a nationwide basis.
Methods Nationwide database cohort study using prospectively recorded data from the Danish
Hernia Database from women undergoing elective repair for epigastric hernias, during a 4-year
period (2018-2021). A 100% follow-up was obtained by combining intra-operative data with data
from the National Civil Register (NRC). The primary outcome was operation for recurrence,
secondary outcomes were readmission and operation for complications. We compared open vs.
laparoscopic repairs, and subgroup analysis were made for open repairs (sutured vs. mesh).